AFFIMED N.V.       EO-,10
AFFIMED N.V. EO-,10
Aktie · NL0015001ZQ0 · AFMD · A407ZR (XNCM)
Übersicht
Kein Kurs
n/a
1 Tag
-
1 Woche
-
1 Monat
-
3 Monate
-
6 Monate
-
Jahr bis heute
-
1 Jahr
-
2 Jahre
-
3 Jahre
-
4 Jahre
-
5 Jahre
-
10 Jahre
-
20 Jahre
-
Max
-
Aktuelle Kurse von AFFIMED N.V. EO-,10
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
AFMD
USD
17.06.2025 20:00
0,18 USD
-
Firmenprofil zu AFFIMED N.V. EO-,10 Aktie
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; AFM28, an innate cell engager (ICE), which is in preclinical development to treat acute myeloid leukemia; and AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. Affimed N.V. has collaboration agreements with The University of Texas MD Anderson Cancer Center; Genentech, Inc.; and Roivant Sciences Ltd., as well as research funding agreement with The Leukemia & Lymphoma Society. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany.

Unternehmensdaten

Name AFFIMED N.V. EO-,10
Firma Affimed N.V.
Symbol AFMD
Website https://www.affimed.com
Heimatbörse XNCM Frankfurt
WKN A407ZR
ISIN NL0015001ZQ0
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Shawn M. Leland Pharm.D.,
Land Deutschland
Währung EUR
Mitarbeiter 0,1 T
Adresse Technologiepark, 69120 Mannheim
IPO Datum 2014-09-12

Ticker Symbole

Name Symbol
Frankfurt A28A.F
NASDAQ AFMD
Weitere Aktien
Investoren, die AFFIMED N.V. EO-,10 halten, haben auch folgende Aktien im Depot:
TORONTO-DOMINION BANK FLTG RTE SER CBL18 CVRD BDS 30/01/23
TORONTO-DOMINION BANK FLTG RTE SER CBL18 CVRD BDS 30/01/23 Anleihe
TRACTION URANIUM CORP
TRACTION URANIUM CORP Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025